Clinical trial
A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough
NCT01656668 is registered in ClinicalTrials.gov with Respicopea Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Double-Blind, Placebo-Controlled, Adaptive Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough
- Lead sponsor
- Respicopea Limited
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 288 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.